Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
10.1136/adc.82.1.67
People are increasingly aware of the benefits and applications of GLP-1agonists in managing diabetes and obesity
When someone struggles with weight, they often struggle with much more than the number on the scale
Glucagon-Like Peptide 1 (GLP-1) Agonists Market Regional Analysis North America dominated the Glucagon-Like Peptide 1 (GLP-1) Agonists market and accounted for the largest revenue share of 41.38% in 2025 , supported by the high prevalence of type 2 diabetes and obesity, strong adoption of innovative GLP-1 receptor agonist therapies, and the presence of leading pharmaceutical manufacturers
People need to understand the risk of relatively rapid weight regain if medication stops that should be part of informed decision-making from the beginning, he says
US$ 21.34
US$ 26.83
US$ 20.74
